Skip to main content
BNR logo

Burning Rock Biotech Limited

BNRNASDAQHealthcareDiagnostics & Research

$11.15Today:- (-)1Y +26.67%

As of Oct 26, 2026 close

Market cap
$121.09M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.79$41.72
Volume (live)
-
Avg. volume (3M)
31.93K

Burning Rock Biotech (BNR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Burning Rock Biotech reported total assets of CNY 820.38M and total liabilities of CNY 285.11M. Shareholders' equity was CNY 535.26M, down 7.8% from CNY 580.83M a year earlier. Total debt stood at CNY 1.90M against CNY 480.79M in cash and short-term investments, a net cash position of CNY 478.89M. That puts debt-to-equity at 0.00, compared with 0.09 a year earlier.

Burning Rock Biotech Balance Sheet Analysis

Values in billions CNY

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Burning Rock Biotech Limited (BNR) - Annual data in billions CNY
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents0.480.520.620.911.431.900.090.090.05
Short-Term Investments0.000.010.010.000.060.370.310.040.14
Cash & Short-Term Investments0.480.530.630.911.502.260.410.130.19
Accounts Receivable0.180.170.150.110.090.110.090.040.04
Inventory0.060.060.070.130.120.070.060.050.02
Other Current Assets0.030.030.050.010.000.090.150.030.05
Total Current Assets0.740.780.881.261.822.520.710.290.30
Non-Current Assets
Property, Plant & Equipment (Net)0.070.100.140.300.410.110.090.070.06
Long-Term Investments0.000.000.010.000.000.000.040.000.04
Goodwill0.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.010.000.000.000.00
Other Non-Current Assets0.010.010.010.020.050.020.010.010.00
Total Non-Current Assets0.080.110.160.330.460.140.140.080.10
Total Assets0.820.891.041.592.282.660.850.370.40
Current Liabilities
Accounts Payable0.040.030.020.050.060.040.010.020.00
Short-Term Debt0.000.020.010.040.000.030.040.180.01
Current Portion of Long-Term Debt0.00----0.03---
Accrued Liabilities0.080.090.100.100.110.07---
Deferred Revenue0.110.120.130.150.140.070.050.060.00
Other Current Liabilities0.000.000.000.020.010.010.050.030.05
Total Current Liabilities0.250.270.260.410.370.240.160.280.08
Non-Current Liabilities
Long-Term Debt0.000.030.000.010.050.000.020.090.15
Other Non-Current Liabilities0.010.010.000.000.010.001.550.600.00
Total Non-Current Liabilities0.040.040.010.020.060.001.570.690.15
Total Liabilities0.290.300.270.430.430.241.740.980.23
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.000.000.00
Retained Earnings-4.26-4.20-3.85-3.20-2.23-1.42-0.95-0.61-0.38
Accumulated Other Comprehensive Income-0.16-0.16-0.16-0.17-0.21-0.170.01-0.01-0.01
Treasury Stock0.060.060.070.06-----
Additional Paid-in Capital4.965.004.784.584.284.010.050.020.02
Shares Outstanding0.110.110.100.100.11----
Total Stockholders' Equity0.540.580.771.161.852.42-0.89-0.600.17
Total Liabilities & Equity0.820.891.041.592.282.660.850.370.40

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Burning Rock Biotech Balance Sheet

How much debt does Burning Rock Biotech have?

Burning Rock Biotech had total debt of CNY 1.90M as of Dec 31, 2025, against CNY 480.79M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was CNY 52.32M a year earlier.

What are Burning Rock Biotech's total assets?

Burning Rock Biotech reported total assets of CNY 820.38M as of Dec 31, 2025, down 7.3% from CNY 885.30M a year earlier. Total liabilities were CNY 285.11M.

What is Burning Rock Biotech's shareholders' equity?

Burning Rock Biotech's shareholders' equity was CNY 535.26M as of Dec 31, 2025, or about CNY 5.09 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition